Medicines in ATC group L — Antineoplastic and immunomodulating agents
Overview of medicines in ATC class L (Antineoplastic and immunomodulating agents) and their availability in Belgian pharmacies.
1878 medicines
- Sarclisa 20 mg/ml
- Sarclisa 20 mg/ml
- Sarclisa 20 mg/ml
- Scemblix 20 mg — asciminib
- Scemblix 40 mg — asciminib
- Siklos 100 mg — hydroxycarbamide
- Simponi 100 mg — golimumab
- Simponi 100 mg — golimumab
- Simponi 50 mg — golimumab
- Simponi 50 mg — golimumab
- Simponi 50 mg — golimumab
- Simponi 50 mg — golimumab
- Simponi 50 mg — golimumab
- Simponi 50 mg — golimumab
- Simponi 50 mg — golimumab
- Simponi 50 mg — golimumab
- Simulect 20 mg — basiliximab
- Simulect 20 mg
- Skilarence 120 mg — dimethylfumaraat
- Skilarence 30 mg — dimethylfumaraat
- Skyrizi 150 mg — risankizumab
- Skyrizi 150 mg — risankizumab
- Skyrizi 180 mg — risankizumab
- Skyrizi 360 mg — risankizumab
- Skyrizi 600 mg — risankizumab
- Skyrizi 75 mg
- Soliris 300 mg — eculizumab
- Sorafenib EG 400 mg
- Sorafenib EG 200 mg — sorafenib
- Sorafenib Sandoz 200 mg — sorafenib
- Sorafenib Sandoz 400 mg
- Sotyktu 6 mg — deucravacitinib
- Spexotras 0.05 mg/ml — trametinib
- Sprycel 10 mg/ml
- Sprycel 100 mg — dasatinib
- Sprycel 100 mg — dasatinib
- Sprycel 100 mg — dasatinib
- Sprycel 20 mg — dasatinib
- Sprycel 20 mg — dasatinib
- Sprycel 50 mg — dasatinib
- Sprycel 50 mg — dasatinib
- Sprycel 50 mg — dasatinib
- Sprycel 70 mg — dasatinib
- Sprycel 70 mg — dasatinib
- Stelara 130 mg — ustekinumab
- Stelara 45 mg — ustekinumab
- Stelara 45 mg — ustekinumab
- Stelara 45 mg — ustekinumab
- Stelara 45 mg — ustekinumab
- Stelara 90 mg — ustekinumab
- Stelara 90 mg — ustekinumab
- Steqeyma 130 mg — ustekinumab
- Steqeyma 45 mg — ustekinumab
- Steqeyma 45 mg — ustekinumab
- Steqeyma 90 mg — ustekinumab
- Steqeyma 90 mg — ustekinumab
- Steqeyma 90 mg — ustekinumab
- Stivarga 40 mg — regorafenib
- Sunitinib EG 12.5 mg — sunitinib
- Sunitinib EG 25 mg — sunitinib